- News & updates
Strand Life Sciences Creates Another Global Bioinformatics Landmark With Strand Ramanujan (Apr 03, 2017)
Strand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmark. Strand Life Sciences today announced the release of version 3.0 of its flagship, next-generation sequencing (NGS) data analysis and visualization platform, Strand NGS. Benchmarked against the world’s best, major enhancements in this release have led to significant improvements in accuracy, precision, and speed of NGS data analysis at scientists’ fingertips
Strand Life Sciences Announces Key Publication Demonstrating Clinical Utility of its Germline Cancer Multi-gene Test for Hereditary Breast and Ovarian Cancer (HBOC) (Mar 03, 2016)
Strand Life Sciences, a global leader in precision medicine diagnostics announced the publication of a landmark study in the Journal of Human Genetics in a paper titled, “Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India.”
Strand Life Sciences’ NGS Laboratory First in India to Receive Both CAP and NABL Accreditations (Feb 25, 2016)
Strand Life Sciences, a global genomic profiling company aimed at empowering personalized cancer care and genetic testing for inherited diseases, announced that its Next-Generation Sequencing (NGS) laboratory, the Strand Center for Genomics & Personalized Medicine, located at Bangalore, has recently received certificates of accreditation from the College of American Pathologists (CAP), and..
Genomic Testing to be Harnessed for Precision Medicine in Oncology (Dec 12, 2015)
Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise by about 70 percent over the next two decades (Source: World Health Organisation). With the genomic profile of each cancer patient being unique, oncologists are faced with the challenging task of deciding a specific treatment that works best for them. Keeping this in mind..
Avadis NGS becomes Strand NGS with version 2.0 release (July 02, 2014)
Strand Life Sciences (Strand) announced today the version 2.0 release of its popular next-generation sequencing (NGS) data analysis and visualization platform, Avadis NGS, under a new name: Strand NGS. Strand NGS is built on the same award winning platform as Strand and Agilent Technologies’ GeneSpring®..
Strand Genomics Announces Availability Of Technology Solutions To Power Expansion Of Personalized Medicine Centers In U.S. (April 01, 2014)
Strand Genomics, Inc. (Strand) today announced its recent unveiling of a full suite of technology solutions that will support its expansion of Strand Centers for Genomics & Personalized Medicine (Strand Centers) into the U.S..
Strand Releases Enterprise Server Edition to Avadis-NGS, Establishes Reads to Reporting Solution for Clinical Genomics (April 01, 2014)
At the ACMG Annual Clinical Genetics meeting this week, Strand Life Sciences and Strand Genomics announced the release of the Avadis-NGS Server Edition, an enterprise solution to their widely adopted Next Generation Sequencing analytics platform..
Strand - News and Events
Visit to know about latest updates and promotions
BIOBASE Genome Trax and Avadis NGS (June 30, 2011)
Strand and BIOBASE have joined forces to give Avadis NGS users easy, one-click access to the superior, human curated biological databases contained in BIOBASE’s Genome Trax
Screenshot of Avadis NGS on Madern Pharmaceuticals issue (October 5, 2010)
A screenshot of Avadis NGS (http://strand-ngs.com) on the cover of October 2010 issue of Modern Pharmaceuticals
Avadis NGS Launch (October 5, 2010)
Strand releases Avadis NGS software to enable biologists to analyze next-generation sequence data